TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AMPX

Amprius Technologies Inc.

Industrials · Electrical Equipment & Parts

9.50$ +4.8% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Amprius Technologies Inc. (AMPX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/04/2026
Earnings surprise by quarter (%)
Q3 23 · 16.7 % 23 Q4 23 · 9.1 % 23 Q1 24 · 8.3 % 24 Q2 24 · -30.0 % 24 Q3 24 · -1,100.0 % 24 Q4 24 · 7.7 % 24 Q1 25 · 11.1 % 25 Q2 25 · 37.5 % 25 Q3 25 · 50.0 % 25 Q4 25 · 79.4 % 25 Q1 26 · -300.0 % 26 Q2 26 · 0.0 % 26

EPS estimate beaten

Full history 10 of 17 quarters (59%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/07/2026 Earnings Call Q1 2026 Open →
  • 03/05/2026 Earnings Call Q4 2025 Open →
  • 11/07/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →
  • 05/08/2025 Earnings Call Q1 2025 Open →
  • 03/20/2025 Earnings Call Q4 2024 Open →
  • 11/09/2024 Earnings Call Q3 2024 Open →
  • 08/08/2024 Earnings Call Q2 2024 Open →
  • 05/09/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/13/2026 Amprius Technologies, Inc. (AMPX): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/04/2026 Amprius Technologies, Inc. (AMPX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?